These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35347398)

  • 1. Prognostic role of infracentimetric colorectal liver metastases.
    Frosio F; Cervantes B; Nassar A; Faermark N; Sanou Y; Bonnet S; Lefevre M; Louvet C; Gayet B; Fuks D
    Langenbecks Arch Surg; 2022 Aug; 407(5):1971-1980. PubMed ID: 35347398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 3. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases.
    Zhai Y; Bai W; Zhou J; Dong Q; Zhang J
    BMC Cancer; 2022 Jan; 22(1):103. PubMed ID: 35078439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
    Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
    Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
    Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of surgical margins on overall and recurrence-free survival in parenchymal-sparing laparoscopic liver resections of colorectal metastases.
    Montalti R; Tomassini F; Laurent S; Smeets P; De Man M; Geboes K; Libbrecht LJ; Troisi RI
    Surg Endosc; 2015 Sep; 29(9):2736-47. PubMed ID: 25427420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
    Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
    Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases.
    Yoshimoto T; Morine Y; Imura S; Ikemoto T; Iwahashi S; Saito YU; Yamada S; Ishikawa D; Teraoku H; Yoshikawa M; Higashijima J; Takasu C; Shimada M
    In Vivo; 2017; 31(3):419-423. PubMed ID: 28438872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of autotransfusion on recurrence of colorectal cancer liver metastasis: Long-term follow-up of patients undergoing curative intent hepatectomy.
    Wehrle CJ; Perlmutter B; Hong H; Chang J; Stackhouse KA; Naples R; Shanaz Hossain M; Joyce D; Simon R; Kim J; Naffouje SA; Aucejo F; Kwon DCH; Walsh RM; Augustin T
    J Surg Oncol; 2024 Mar; 129(4):793-801. PubMed ID: 38151831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis: Who benefits?
    Wong LH; Sutton TL; Walker BS; Lopez CD; Kardosh A; Eil RL; Chen EY; Billingsley KG; Mayo SC
    Am J Surg; 2021 Jun; 221(6):1114-1118. PubMed ID: 33722380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence patterns after laparoscopic resection of colorectal liver metastases.
    Tabchouri N; Gayet B; Okumura S; Donatelli G; Beaussier M; Bennamoun M; Louvet C; Fuks D
    Surg Endosc; 2018 Dec; 32(12):4788-4797. PubMed ID: 29761279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
    Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
    Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Metformin Use on Survival in Patients Undergoing Liver Resection for Colorectal Cancer Metastases.
    Kaltenmeier C; Morocco B; Yazdani H; Reitz K; Meyer K; Molinari M; Geller D; Tohme S
    Am Surg; 2021 Nov; 87(11):1766-1774. PubMed ID: 34766506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.
    Watanabe A; Araki K; Harimoto N; Kubo N; Igarashi T; Ishii N; Yamanaka T; Hagiwara K; Kuwano H; Shirabe K
    Int J Clin Oncol; 2018 Aug; 23(4):689-697. PubMed ID: 29574651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
    J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.